Extrait

Background and study aims We all need to make decisions about our health and treatments, and health and health research are often in the news. Information about treatments is sometimes confusing or hard to understand. To make it easier to understand for people making a decision about a treatment, we would like members of the public to test some different ways health research information can be presented. The DECIDE project is working to find ways to present information about treatments to all the people involved in making healthcare decisions, including patients and their families, healthcare managers, doctors, nurses and other health professionals. This is an important part of providing high quality healthcare. Who can participate? People aged over 18 who are on the SHARE online database of people in Scotland who are interested in participating in trials. What does the study involve? We have prepared some information on using the following treatments: antibiotics for middle ear infection; aspirin for primary prevention of cardiovascular disease; warfarin for atrial fibrillation. This information is based on the best research about treatment options for these health problems. We have prepared different ways of presenting this information. Participants are randomly allocated to be shown one of three ways of presenting information about one of these topics so that we can get their opinion on how helpful the information is. Completing the study takes around 15 minutes. What are the possible benefits and risks of participating? We aim to ask thousands of people to give their opinion, which will give a good idea of what works and what doesn’t. Taking part in the study won’t lead to an immediate benefit for participants personally. However, it will help organisations that produce health information improve the way they do this. This may be help people in the future when making real decisions about treatments. Where is the study run from? 1. Health Services Research Unit at the University of Aberdeen (UK) 2. Norwegian Knowledge Centre for the Health Services (Norway) When is the study starting and how long is it expected to run for? November 2014 to January 2016 Who is funding the study? The European Union (Belgium) Who is the main contact? Prof. Shaun Treweek [email protected]

Critère d'inclusion

• Understanding and satisfaction with evidence-based information about the harms and benefits of treatments

Liens

• isrctn
• ictrp